Bio-Path Holdings, Inc.

NasdaqCM:BPTH Stock Report

Market Cap: US$4.6m

Bio-Path Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BPTH?
Owner TypeNumber of SharesOwnership Percentage
Private Companies4100.00952%
Institutions59,0491.37%
Individual Insiders391,0169.08%
General Public3,856,41789.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 597.3%.

Top Shareholders

Top 20 shareholders own 10.46% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.52%
Mitchell Kopin
194,862US$208.5k0%no data
4.52%
Daniel Asher
194,862US$208.5k0%no data
0.32%
Geode Capital Management, LLC
13,598US$14.6k25.1%no data
0.31%
The Vanguard Group, Inc.
13,502US$14.4k0%no data
0.29%
Virtu Financial LLC, Asset Management Arm
12,325US$13.2k0%no data
0.25%
Citadel Advisors LLC
10,917US$11.7k0%no data
0.078%
Tower Research Capital Europe Limited
3,371US$3.6k-9.7%no data
0.066%
UBS Asset Management AG
2,856US$3.1k232%no data
0.055%
BlackRock, Inc.
2,381US$2.5k0%no data
0.03%
Peter Nielsen
1,292US$1.4k0%no data
0.0094%
Hyacinth Resources, LLC
403US$431.30%no data
0.00081%
Morgan Stanley, Investment Banking and Brokerage Investments
35US$37.30%no data
0.00049%
Group One Trading LP, Asset Management Arm
21US$22.60%no data
0.00046%
Bank of America Corporation, Asset Management Arm
20US$21.2-48.7%no data
0.00023%
EverSource Wealth Advisors, LLC
10US$10.60%no data
0.00016%
Merrill Lynch & Co. Inc., Banking Investments
7US$7.40%no data
0.00016%
Sycamore Ventures, LLC
7US$7.40%no data
0.00009%
Global Retirement Partners, LLC
4US$4.10%no data
0.00002%
Allworth Financial, L.P.
1US$0.90%no data
0.00002%
Blackstone Alternative Investment Advisors LLC
1US$0.90%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 05:12
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bio-Path Holdings, Inc. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason KolbertMaxim Group
Pamela BassettMaxim Group
Raghuram SelvarajuRodman & Renshaw, LLC